🇺🇸 FDA
Pipeline program

0.9% sodium chloride, GADOTERIC ACID

J3K-MC-KIAB

Phase 2 small_molecule active

Quick answer

0.9% sodium chloride, GADOTERIC ACID for Relapsing Multiple Sclerosis is a Phase 2 program (small_molecule) at Eli Lilly Co. with 1 ClinicalTrials.gov record(s).

Program details

Company
Eli Lilly Co.
Indication
Relapsing Multiple Sclerosis
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials